FDA Proposes Stricter Rules On Drug Label Changes

Law360, New York (January 16, 2008, 12:00 AM EST) -- The U.S. Food and Drug Administration has published proposed regulation changes to drug and medical device labeling that would restrict the rights of pharmaceutical manufacturers to change product labels without agency approval.

The proposed revision comes as the U.S. Supreme Court considers whether to hear argument by drugmaker Wyeth Pharmaceuticals Inc. that federal laws governing labeling take precedence over state product liability legislation.

The new rules, if adopted, would limit the ability of drug companies to unilaterally alter labels under a “changes being effected” product supplement...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.